Task Force Product Expert
Servier
Total years of experience :8 years, 3 Months
Participated efficiently in the development and managed the implementation of the launch plan for the CNS line in the central region of Saudi Arabia with full responsibility of selecting, developing and managing the advisory board, thought leaders and local speakers and to develop/achieve hospitals and pharmacies introduction plan in addition to full responsibility for achieving the annual & monthly sales targets, I also participated in the expansion plan and in the selection of the team new candidates.
STAR: launched the anti-diabetic product Diamicron MR in MOH sector with full responsibility of generating department's requests for the SGH34 tender quantities and Direct Purchasing Orders (DPO's) along with maintaining a high demand for the mature anti-hypertensive product Natrilix SR resulted in the tremendous achievement of 130% quantities vs budget.
• Central region: Private and Public sectors.
• Launching: Central Nervous System (CNS) Line / VALDOXAN®.
• Therapeutic Area: Depression, Diabetes, Cardiovascular.
• Brands: (VALDOXAN®, Diamicron MR®, NATRILIX SR®)
• 500’000 SR turnover & 101% achievement versus annual Targets for CNS line.
• 5.5 Million SR turnover & 130% achievement versus SGH34 tender targets for MOH line.
• Targeting: Neuro-Psychiatrists Endocrinologists Cardiologists Internists Primary Care.
Fully responsible for the achievement of the annual and monthly targets as well as educating the targeted doctors about the benefits of my product line, handling their objections, influencing their practice, and generating high volume of prescriptions in the right patient segment to create demand and achieve leadership in sales & market share.
• Central region: Private sector.
• Launching: Osteoporosis Line / Protelos®: “Award of successful launch."
• Therapeutic Area: Osteoporosis, Diabetes, Cardiovascular, Depression, Venous insufficiency, Hemorrhoids.
• Brands: (Protelos®, DiamicronMR®, BiPreterax® Coversyl®, VastarelMR®, Stablon®, Daflon®)
• Targeting: Orthopedics Endocrinologists Cardiologists Internists Primary Care Psychiatrists.